Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Apellis Pharmaceuticals, Inc.

APLS

Valuace

Růst

100

Zdraví

Cena

$ 40.40

-0.59 (-2.87%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Total Revenues	1,003.8	1,003.8	781.4	396.6	75.4	66.6	250.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of Revenues	102.7	102.2	117.7	58.5	5.6	5.2	25.1	288.0	127.9	50.8	0.0	0.0	0.0	0.0
Gross Profit	901.1	901.5	663.6	338.1	69.8	61.4	225.6	-288.0	-127.9	-50.8	0.0	0.0	0.0	0.0

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	199.9	458.6	178.5	166.8	212.5	196.8	199.7	172.3	146.4	99.2
Cost of Revenues	29.7	24.5	14.1	34.4	40.9	33.6	23.5	20.7	19.9	22.4
Gross Profit	170.2	434.0	164.4	132.4	171.7	163.3	176.1	151.7	126.5	76.8

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
R&D Expenses	0.0	0.0	0.0	354.4	387.2	420.9	299.9	221.0	105.3	40.3	23.0	13.7	8.4	2.3
Selling General & Admin Expenses	0.0	0.0	0.0	500.8	277.2	176.8	139.4	67.0	22.6	10.5	4.3	6.4	2.9	1.7
Depreciation & Amortization	1.6	1.6	1.8	1.7	10.1	3.3	4.3	5.2	2.9	0.0	0.0	53.0	0.0	0.0
Total Operating Expenses	845.7	846.1	828.6	855.2	664.4	597.6	439.3	288.0	127.9	50.8	27.3	20.1	11.3	4.0
Operating Income	55.4	55.4	-165.0	-517.1	-594.6	-536.3	-213.7	-288.0	-127.9	-50.8	-27.3	-46.6	-11.3	-4.0

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.3	79.4
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141.7	145.6
Depreciation & Amortization	0.3	0.3	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.4
Total Operating Expenses	221.3	210.9	197.7	215.8	197.8	210.6	205.6	213.8	211.0	225.1
Operating Income	-51.1	223.2	-33.3	-83.3	-26.2	-47.3	-29.4	-62.1	-84.5	-148.3

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Interest Income	13.1	13.1	12.8	20.9	8.9	0.4	4.2	5.1	3.0	0.0	0.0	0.0	0.0	0.0
Interest Expense	44.3	44.3	40.4	29.6	32.6	13.2	29.9	5.3	2.5	-0.1	0.0	0.0	0.0	0.0
Other Expense	-31.3	-31.3	-31.7	-9.4	-56.9	-209.7	-129.3	-16.7	0.0	-0.1	0.2	-26.5	0.1	0.1
IBT	24.1	24.1	-196.7	-526.5	-651.5	-746.0	-343.0	-304.7	-127.5	-51.0	-27.1	-46.5	-11.2	-4.0
Income Tax Expense	1.7	1.7	1.2	2.1	0.7	0.4	1.8	5.1	-0.5	0.3	0.0	-26.5	-0.4	0.0
Net Income	22.4	22.4	-197.9	-528.6	-652.2	-746.4	-344.9	-309.8	-127.5	-51.0	-27.1	-46.5	-10.8	-4.0

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	3.5	4.4	2.6	2.7	3.4	2.9	3.2	3.3	4.5	5.0
Interest Expense	10.8	11.3	11.2	11.0	11.5	12.5	9.4	7.0	7.4	7.3
Other Expense	-7.5	-6.9	-8.4	-8.6	-9.9	-9.6	-8.1	-4.2	-2.6	-2.9
IBT	-58.6	216.3	-41.7	-91.9	-36.1	-56.9	-37.5	-66.3	-87.2	-140.0
Income Tax Expense	0.3	0.6	0.5	0.3	0.3	0.6	0.1	0.2	1.4	0.2
Net Income	-59.0	215.7	-42.2	-92.2	-36.4	-57.4	-37.7	-66.4	-88.6	-140.2

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
EPS	$0.00	$0.00	$0.00	$-4.45	$-8.68	$-8.84	$-4.59	$-4.98	$-2.34	$-3.68	$-1.50	$-2.57	$-0.60	$-0.22
EPS Diluted	$0.00	$0.00	$0.00	$-4.45	$-8.68	$-8.84	$-4.59	$-4.98	$-2.34	$-3.68	$-1.50	$-2.57	$-0.60	$-0.22
Shares Outstanding	126.0	126.0	123.9	118.7	75.2	84.4	75.2	62.2	54.4	13.9	18.1	18.1	18.1	18.1
Diluted Shares Outstanding	126.0	126.0	123.9	118.7	75.2	84.4	75.2	62.2	54.4	13.9	18.1	18.1	18.1	18.1

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.73	$-1.17
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.73	$-1.17
Shares Outstanding	126.0	126.0	126.0	125.5	123.9	123.9	123.9	123.0	121.2	120.3
Diluted Shares Outstanding	126.0	126.0	126.0	125.5	123.9	123.9	123.9	123.0	121.2	120.3

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash And Equivalents	361.4	411.3	351.2	551.8	640.2	565.8	352.0	176.3	175.6	24.9	36.0	13.6	4.8
Short Term Investments	8.0	4.8	1.1	0.0	60.4	311.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Cash & ST Investments	361.4	416.1	352.3	551.8	700.6	877.6	352.0	176.3	175.6	24.9	36.0	13.6	4.8
Accounts Receivable	308.9	271.7	206.4	7.7	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1
Inventory	152.8	82.5	146.4	85.7	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3
Other Current Assets	36.9	18.6	61.2	36.7	70.7	26.9	1.3	1.8	1.3	2.5	2.0	0.0	0.0
Total Current Assets	860.0	789.0	766.3	719.5	824.0	917.2	373.1	202.4	182.0	27.4	38.0	14.2	5.2

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	479.2	371.5	358.4	411.3	396.9	360.1	327.0	352.3	452.4	616.3
Short Term Investments	0.0	0.0	0.0	4.8	0.0	8.0	0.0	4.4	13.1	9.4
Total Cash & ST Investments	479.2	371.5	358.4	416.1	396.9	368.0	327.0	352.3	452.4	616.3
Accounts Receivable	354.6	229.2	244.4	271.7	284.0	308.9	267.8	206.4	187.0	128.3
Inventory	122.8	121.0	82.5	82.5	121.1	162.2	161.3	146.4	98.5	103.2
Other Current Assets	34.1	33.9	42.5	18.6	32.0	20.9	55.3	61.2	58.8	44.9
Total Current Assets	990.7	755.6	727.7	789.0	833.9	860.0	811.4	766.3	796.8	892.7

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Property, Plant & Equipment	20.2	19.0	21.1	24.9	26.1	24.5	15.8	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets	24.4	77.1	1.3	15.8	31.6	18.9	0.4	1.1	0.1	0.1	0.1	0.0	0.0
Total Long-Term Assets	44.5	96.1	22.4	40.7	57.7	43.4	16.2	1.1	0.1	0.1	0.1	0.1	0.0
Total Assets	904.5	885.1	788.7	760.2	881.8	960.6	389.2	203.5	182.1	27.4	38.2	14.3	5.2

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	21.6	16.8	17.8	19.0	20.4	20.2	19.2	21.1	20.3	22.1
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets	46.4	49.0	61.8	77.1	47.5	24.4	1.3	1.3	1.2	0.8
Total Long-Term Assets	68.0	65.8	79.6	96.1	68.0	44.5	20.5	22.4	21.4	22.9
Total Assets	1,058.7	821.4	807.3	885.1	901.9	904.5	831.9	788.7	818.2	915.6

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Accounts Payable	38.3	38.6	37.5	37.3	16.9	8.5	8.4	10.3	3.7	2.5	2.5	0.8	0.4
Short-Term Debt	6.2	6.8	6.4	5.6	4.1	3.7	2.6	1.7	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	122.8	140.2	203.6	124.6	7.6	4.2	54.8	5.1	2.9	1.1	0.7	0.3	0.3
Current Liabilities	169.2	185.5	247.6	167.6	131.8	128.3	65.8	17.0	6.6	3.6	3.2	1.1	0.7

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	38.6	54.2	55.3	38.6	42.7	38.3	26.8	37.5	18.2	27.5
Short-Term Debt	100.6	7.4	6.9	6.8	6.8	6.2	89.8	6.4	5.7	5.9
Other Current Liabilities	140.3	139.0	116.1	140.2	139.8	124.7	95.1	203.6	161.7	141.5
Current Liabilities	279.5	200.7	178.4	185.5	191.3	169.2	215.3	247.6	185.6	174.8

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Long-Term Debt	457.2	463.0	104.5	107.1	206.1	374.0	154.4	25.4	26.4	0.0	0.0	0.0	0.0
Capital Leases	11.1	17.0	17.9	20.0	21.2	18.9	14.5	0.0	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	640.2	656.5	594.2	590.3	683.1	756.0	355.0	42.6	33.2	3.6	3.2	1.1	0.7

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	374.8	462.3	462.6	463.0	463.7	468.3	102.9	104.5	103.8	104.9
Capital Leases	20.7	7.4	16.1	17.0	18.2	17.3	9.8	11.5	16.6	17.9
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	657.6	665.1	643.1	656.5	664.7	640.2	565.3	594.2	585.9	570.2

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-2,941.6	-3,035.4	-2,837.5	-2,308.9	-1,656.7	-926.3	-581.5	-276.8	-149.3	-98.3	-71.1	-24.6	-13.8
Comprehensive Income	-3.4	-3.3	-3.5	-0.9	-2.1	-0.1	-0.2	-0.1	0.0	0.0	0.0	0.0	0.0
Total Common Equity	264.3	228.5	194.5	169.9	198.7	204.6	34.2	161.0	148.9	23.8	35.0	13.2	4.5

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-2,954.0	-3,169.7	-3,127.6	-3,035.4	-2,999.0	-2,941.6	-2,903.9	-2,837.5	-2,748.9	-2,608.7
Comprehensive Income	-2.4	-2.6	-3.1	-3.3	-3.1	-3.4	-3.5	-3.5	-1.1	-0.8
Total Common Equity	401.2	156.3	164.2	228.5	237.1	264.3	266.7	194.5	232.3	345.4

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Total Debt		474.5	469.8	110.9	112.7	210.2	377.7	157.0	27.0	26.4	0.0	0.0	0.0	0.0
Book Value		264.3	228.5	194.5	169.9	198.7	204.6	34.2	161.0	148.9	23.8	35.0	13.2	4.5

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		401.2	156.3	164.2	228.5	237.1	264.3	266.7	194.5	232.3	345.4

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-332.9	22.4	-197.9	-528.6	-652.2	-746.4	-344.9	-304.7	-127.5	-51.0	-27.1	-46.5	-10.8	-4.0
Depreciation & Amortization	1.8	0.0	1.8	1.7	1.5	1.5	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0
Stock-Based Compensation	108.2	0.0	114.1	105.9	91.1	70.7	45.4	21.1	7.7	5.4	1.1	0.5	0.7	0.3
Change Working Capital	-209.7	-85.1	-18.4	-200.2	-15.7	-93.5	19.6	53.1	-12.0	-1.2	0.0	0.6	0.2	0.2
Change In Accounts Receivable	-193.5	-101.3	-58.5	0.0	2.4	-10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Change In Accounts Payable	10.8	18.2	1.1	0.2	18.7	10.5	-0.1	-1.6	6.6	0.9	0.1	1.7	0.4	0.2
Change In Inventories	-72.6	-15.3	-10.8	0.0	-69.4	-16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-cash Items	213.2	108.1	12.4	26.4	61.6	6.3	15.8	2.7	0.6	0.0	0.0	26.5	0.0	0.3
Cash from Operations	-408.3	0.0	0.0	-594.7	-513.7	-563.1	-160.5	-211.1	-131.2	-46.6	-26.0	-18.9	-9.9	-3.4

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	-81.3	215.7	-42.2	-92.2	-36.4	-57.4	-37.7	-66.4	-88.6	-140.2
Depreciation & Amortization	-1.2	0.3	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.4
Stock-Based Compensation	-82.8	28.2	27.2	27.4	0.0	27.5	30.0	30.3	26.2	21.6
Change Working Capital	22.5	-136.4	18.3	10.4	28.4	62.8	-6.2	-103.5	-42.6	-57.5
Change In Accounts Receivable	-20.7	-131.4	21.1	29.7	14.1	25.4	-36.6	-61.4	-37.2	-58.4
Change In Accounts Payable	18.2	-15.6	-1.0	16.7	1.5	-1.2	11.5	-10.7	19.6	-9.6
Change In Inventories	-8.7	5.4	-26.0	14.0	10.0	8.7	-14.5	-14.9	-47.8	4.7
Other Non-cash Items	128.6	0.6	0.6	0.6	26.9	0.8	5.1	6.1	6.7	6.5
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-97.9	-169.1

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019
Capital Expenditure	-0.5	-0.3	-0.4	-0.8	-1.5	-1.1	-5.4	-1.7
Acquisitions	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Investments	0.0	0.0	0.0	0.0	-331.9	-171.3	-879.1	0.0
Sales of Investment	0.0	0.0	0.0	0.0	393.3	420.0	567.5	0.0
Other Investing Activities	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
Cash from Investing	-0.4	0.0	0.0	-0.7	59.9	247.6	-317.0	-1.7

Cash Flow From Investing Activities	4-2025	3-2025	2-2024	1-2024	4-2023
Capital Expenditure	0.2	-0.1	-0.1	-0.3	-0.1
Acquisitions	0.0	0.0	0.0	0.0	0.1
Investments	0.0	0.0	0.0	0.0	0.0
Sales of Investment	0.0	0.0	0.0	0.0	0.0
Other Investing Activities	0.0	0.0	0.0	0.0	0.1
Cash from Investing	0.0	0.0	0.0	0.0	0.0

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Debt Repaid	-160.6	0.0	0.0	0.0	0.0	0.0	0.0	-28.7	0.0	0.0	0.0	0.0	0.0	-0.3
Debt Issued	524.3	469.8	358.9	-1.8	-97.5	-167.5	220.7	158.7	0.7	26.4	0.0	0.0	0.0	0.3
Issuance of Common Stock	47.5	0.0	0.0	384.4	380.1	380.4	381.4	109.6	131.2	150.1	0.0	0.0	0.0	0.0
Repurchase of Common Stock	0.0	0.0	0.0	0.0	4.2	3.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	-1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	-227.5	0.0	0.0	10.1	-18.7	8.9	309.2	307.7	0.7	47.3	14.9	41.2	18.8	7.4
Cash from Financing	152.5	0.0	0.0	394.5	365.7	392.2	692.2	388.5	131.9	197.4	14.9	41.2	18.8	7.2

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	475.4	5.6	0.2	-0.2	-0.7	-4.1	281.8	81.8	1.4	-1.2
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	5.8
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-1.6	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-2.4	5.7
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-3.9	5.7

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Change in Cash		-255.9	55.1	60.3	-200.8	-88.7	74.7	215.1	175.7	0.6	150.8	-11.1	22.4	8.9	3.7
Closing Cash Balance		361.4	467.8	412.6	352.3	553.1	641.8	567.0	352.0	176.3	175.6	24.9	36.0	13.6	4.8

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		-12.8	109.1	11.6	-52.8	14.4	36.8	34.4	-25.3	-101.2	-163.8
Closing Cash Balance		467.8	480.6	371.5	359.8	412.6	398.2	361.4	327.0	352.3	453.5

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Free Cash Flow		-408.8	45.0	-88.3	-595.5	-515.3	-564.2	-165.9	-212.8	-131.2	-46.6	-26.0	-18.9	-10.0	-3.4
Real Free Cash Flow		-517.0	45.0	-202.4	-701.5	-606.4	-634.9	-211.3	-234.0	-139.0	-52.0	-27.1	-19.4	-10.6	-3.7

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		-14.0	108.3	4.4	-53.4	19.3	34.1	-8.4	-133.3	-98.0	-169.1
Real Free Cash Flow		68.8	80.1	-22.8	-80.8	19.3	6.6	-38.4	-163.6	-124.2	-190.8